
Effect of A Randomized trial of Unruptured Brain Arteriovenous Malformation on Interventional Treatment Rates for Unruptured Arteriovenous Malformations
Author(s) -
Alexandra Reynolds,
Monica L. Chen,
Alexander E Merkler,
Abhinaba Chatterjee,
Iván Díaz,
Babak B. Navi,
Hooman Kamel
Publication year - 2019
Publication title -
cerebrovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 104
eISSN - 1421-9786
pISSN - 1015-9770
DOI - 10.1159/000502314
Subject(s) - medicine , radiosurgery , incidence (geometry) , arteriovenous malformation , randomized controlled trial , population , clinical endpoint , intracranial arteriovenous malformations , surgery , radiation therapy , angiography , cerebral angiography , physics , environmental health , optics
In 2013, investigators from A Randomized Trial of Unruptured Brain Arteriovenous Malformations (AVM; ARUBA) reported that interventions to obliterate unruptured AVMs caused more morbidity and mortality than medical management.